By Eric W. Dolan
Article Reprint
The U.S. Federal Drug Administration in late April approved a study to examine whether the drug ecstasy could help autistic adults suffering from social anxiety. But the first-of-its-kind study still has some hurdles to jump over before it can begin.
“The study could start enrolling subjects in several months,” Brad Burge, the communications director at Multidisciplinary Dssociation for Psychedelic Studies (MAPS), told Raw Story.